Impact BioMedicalIBO
13F holders, Q3 2024 (September 30)1holders
$0.00avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Impact BioMedical Inc (IBO) in their 13F filings. The largest holder was Ferguson Wellman Capital Management, Inc. ($0).
- Company
- Impact BioMedical Inc
- CUSIP
- 452996176
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Ferguson Wellman Capital Management, Inc. | 0.00% | New | 36,364 | $0 |
"% of holder's portfolio" is IBO's weight in each manager's 13F, not the share of Impact BioMedical Inc the manager owns.